NSE BSE
iol chem and pharma ltd stock

IOL CHEM AND PHARMA LTD Share Price

- - (%)
- NSE: IOLCP

IOL CHEM AND PHARMA LTD Share Price Update

As of the latest trading session, IOL CHEM AND PHARMA LTD share price is currently at 415.35, which is up by 18.45 from its previous closing. Today, the stock has fluctuated between 401.50 and 418.00. Over the past year, IOL CHEM AND PHARMA LTD has achieved a return of 8.14 %. In the last month alone, the return has been -0.59 %. Read More...

IOL CHEM AND PHARMA LTD Performance

Day Range

Low401.50 High418.00
403.15

52 Week Range

Low 330.85 High 535.90
403.15

IOL CHEM AND PHARMA LTD Share Price

20413

524164

IOLCP

img img img img
No Data Available

Open Price

403.20

Prev. Close

396.90

Volume (Shares)

154813.00

Total traded value

624.12

Upper Circuit

476.25

Lower Circuit

317.55

Note: The current prices & values are delayed, Login to your account for live updates.

IOL CHEM AND PHARMA LTD Fundamentals


(Standalone)

Market Cap (Cr) 2438.33
PE Ratio (TTM) 17.48
Book Value / Share 274.47
Beta 0.84
ROE 9.66%
EPS (TTM) 23.07
Dividend Yield 1.24%
Net Profit Qtr (Cr) 28.19

IOL CHEM AND PHARMA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 503.92
Operating Expense 473.67
Net Profit 28.19
Net Profit Margin (%) 5.59
Earnings Per Share (EPS) 4.80
EBITDA 57.60
Effective Tax Rate (%) 25.36
Particulars DEC 2023 (Values in Cr)
Revenue 520.39
Operating Expense 496.53
Net Profit 23.23
Net Profit Margin (%) 4.46
Earnings Per Share (EPS) 3.96
EBITDA 52.86
Effective Tax Rate (%) 27.94
Particulars SEP 2023 (Values in Cr)
Revenue 545.30
Operating Expense 501.31
Net Profit 37.79
Net Profit Margin (%) 6.93
Earnings Per Share (EPS) 6.44
EBITDA 71.21
Effective Tax Rate (%) 26.04
Particulars JUN 2023 (Values in Cr)
Revenue 563.18
Operating Expense 508.71
Net Profit 46.21
Net Profit Margin (%) 8.20
Earnings Per Share (EPS) 7.87
EBITDA 79.92
Effective Tax Rate (%) 24.89
Particulars MAR 2023 (Values in Cr)
Revenue 587.21
Operating Expense 508.40
Net Profit 65.27
Net Profit Margin (%) 11.11
Earnings Per Share (EPS) 11.11
EBITDA 104.50
Effective Tax Rate (%) 25.43
Particulars MAR 2024 (Values in Cr)
Revenue 2132.79
Operating Expense 1980.21
Net Profit 135.42
Net Profit Margin (%) 6.34
Earnings Per Share (EPS) 23.07
EBITDA 261.59
Effective Tax Rate (%) 25.85
Particulars MAR 2023 (Values in Cr)
Revenue 2217.11
Operating Expense 2053.19
Net Profit 139.98
Net Profit Margin (%) 6.31
Earnings Per Share (EPS) 23.84
EBITDA 252.09
Effective Tax Rate (%) 26.12
Particulars MAR 2022 (Values in Cr)
Revenue 2184.02
Operating Expense 1979.29
Net Profit 165.66
Net Profit Margin (%) 7.58
Earnings Per Share (EPS) 28.22
EBITDA 274.39
Effective Tax Rate (%) 25.65
Particulars MAR 2021 (Values in Cr)
Revenue 1966.98
Operating Expense 1419.88
Net Profit 444.56
Net Profit Margin (%) 22.60
Earnings Per Share (EPS) 76.21
EBITDA 616.14
Effective Tax Rate (%) 22.19
Particulars MAR 2020 (Values in Cr)
Revenue 1894.47
Operating Expense 1377.25
Net Profit 361.29
Net Profit Margin (%) 19.07
Earnings Per Share (EPS) 63.51
EBITDA 589.90
Effective Tax Rate (%) 32.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 256.81
ROE % 9.60
ROCE % 13.54
Total Debt to Total Equity 0.04
EBITDA Margin 11.33
Particulars MAR 2022 (Values in Cr)
Book Value / Share 237.15
ROE % 12.04
ROCE % 16.20
Total Debt to Total Equity 0.03
EBITDA Margin 12.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 256.61
ROE % 9.66
ROCE % 13.61
Total Debt to Total Equity 0.04
EBITDA Margin 11.37
Particulars MAR 2022 (Values in Cr)
Book Value / Share 236.80
ROE % 12.50
ROCE % 17.09
Total Debt to Total Equity 0.02
EBITDA Margin 12.56
Particulars MAR 2021 (Values in Cr)
Book Value / Share 214.69
ROE % 42.87
ROCE % 53.83
Total Debt to Total Equity 0.03
EBITDA Margin 31.32
Particulars MAR 2020 (Values in Cr)
Book Value / Share 141.36
ROE % 56.11
ROCE % 67.54
Total Debt to Total Equity 0.27
EBITDA Margin 31.14
Particulars MAR 2019 (Values in Cr)
Book Value / Share 81.74
ROE % 66.00
ROCE % 53.02
Total Debt to Total Equity 1.02
EBITDA Margin 24.92
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 21.83
Total Assets 2022.13
Total Liabilities 2022.13
Total Equity 1507.72
Share Outstanding 58705502
Price to Book Ratio 1.10
Return on Assets (%) 6.88
Return on Capital (%) 8.77
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 139.99
Total Assets 1962.30
Total Liabilities 1962.30
Total Equity 1392.28
Share Outstanding 58705502
Price to Book Ratio 1.49
Return on Assets (%) 8.54
Return on Capital (%) 11.68
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 20.90
Total Assets 2020.61
Total Liabilities 2020.61
Total Equity 1506.55
Share Outstanding 58705502
Price to Book Ratio 1.10
Return on Assets (%) 6.92
Return on Capital (%) 8.82
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 137.88
Total Assets 1960.29
Total Liabilities 1960.29
Total Equity 1390.27
Share Outstanding 58705502
Price to Book Ratio 1.49
Return on Assets (%) 8.45
Return on Capital (%) 11.56
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 364.74
Total Assets 1610.09
Total Liabilities 1610.09
Total Equity 1260.43
Share Outstanding 58705502
Price to Book Ratio 2.56
Return on Assets (%) 27.61
Return on Capital (%) 35.27
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 154.65
Total Assets 1169.79
Total Liabilities 1169.79
Total Equity 813.54
Share Outstanding 56887502
Price to Book Ratio 1.25
Return on Assets (%) 30.88
Return on Capital (%) 41.55
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 29.60
Total Assets 941.88
Total Liabilities 941.88
Total Equity 474.34
Share Outstanding 56887502
Price to Book Ratio 2.33
Return on Assets (%) 25.13
Return on Capital (%) 32.34
Particulars MAR 2023 (Values in Cr)
Net Income 188.65
Cash from Operations 169.37
Cash from Investing -120.00
Cash from Financing -4.11
Net change in Cash -1.84
Free Cash Flow 381.19
Particulars MAR 2022 (Values in Cr)
Net Income 224.85
Cash from Operations 155.63
Cash from Investing -120.52
Cash from Financing -1.64
Net change in Cash -29.11
Free Cash Flow 308.91
Particulars MAR 2023 (Values in Cr)
Net Income 189.49
Cash from Operations 170.24
Cash from Investing -119.19
Cash from Financing -4.11
Net change in Cash -0.16
Free Cash Flow 381.53
Particulars MAR 2022 (Values in Cr)
Net Income 222.84
Cash from Operations 153.62
Cash from Investing -120.62
Cash from Financing -1.64
Net change in Cash -31.22
Free Cash Flow 306.90
Particulars MAR 2021 (Values in Cr)
Net Income 571.39
Cash from Operations 522.03
Cash from Investing -317.25
Cash from Financing -58.28
Net change in Cash 4.25
Free Cash Flow 630.24
Particulars MAR 2020 (Values in Cr)
Net Income 533.24
Cash from Operations 587.95
Cash from Investing -184.23
Cash from Financing -271.89
Net change in Cash 14.68
Free Cash Flow 668.23
Particulars MAR 2019 (Values in Cr)
Net Income 336.15
Cash from Operations 340.86
Cash from Investing -63.04
Cash from Financing -197.46
Net change in Cash 12.67
Free Cash Flow 401.39
Company Name Price P/E P/B Market Cap 52 Week Low/High
IOL CHEM AND PHARMA LTD 403.15 17.60 1.46 2366.71 333.00 / 535.60
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
IOL CHEM AND PHARMA LTD 403.15 17.48 1.46 2366.71 333.00 / 535.60
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 413.20
  • 26 Days 412.40
  • 10 Days 418.20
  • 50 Days 401.00
  • 12 Days 420.00
  • 100 Days 399.10
  • 20 Days 419.10
  • 200 Days 461.20
415.15
PIVOT
First Resistance 419.30
Second Resistance 426.40
Third Resistance 430.55
First Support 408.05
Second Support 403.90
Third Support 396.80
RSI 49.77
MACD 7.62
Commodity Channel Index (CCI) -97.52
ADX 43.17
Williams % R -97.76

Over 1 Month

down

-0.59

Over 3 Months

down

4.70

Over 6 Months

down

-11.22

Over 1 Year

down

8.14

Over 3 Years

down

-14.63

Over 5 Years

down

14.60

IOL CHEM AND PHARMA LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

IOL CHEM AND PHARMA LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
50.33
Promoter Holdings
48.18
FII
1.38
DII
0.08
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Maya Devi Polycot Limited Shareholding of Promoter and Promoter Group 1.2647402E7 21.54
Ncvi Enterprises Limited Shareholding of Promoter and Promoter Group 9370139.0 15.96
Nm Merchantiles Pvt Limited Shareholding of Promoter and Promoter Group 5075571.0 8.65
Vasudeva Commercials Limited Public Shareholding 4663859.0 7.94
Enorg Limited Public Shareholding 2602539.0 4.43
Varinder Gupta Shareholding of Promoter and Promoter Group 1195865.0 2.04
G Consultants And Fabricators Pvt Ltd Public Shareholding 989000.0 1.68
Varinder Gupta (huf) Shareholding of Promoter and Promoter Group 1100.0 0.0

IOL CHEM AND PHARMA LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-16 5.0 Interim 2024-02-16 Equity shares 2023-02-17 4.0 Interim 2023-02-17 Equity shares 2022-02-15 4.0 Interim 2022-02-16 Equity shares 2021-09-08 2.0 Final 2021-09-12 Equity shares 2020-11-17 4.0 Interim 2020-11-18 Equity shares 2020-03-18 3.0 Interim 1 2020-03-19 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About IOL CHEM AND PHARMA LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by IOL CHEM AND PHARMA LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of IOL Chemicals & Pharmaceuticals Ltd?

Answer Field

The share price of IOL Chemicals & Pharmaceuticals Ltd for NSE is ₹ 415.35 and for BSE is ₹ 417.

What is the Market Cap of IOL Chemicals & Pharmaceuticals Ltd?

Answer Field

The market cap of IOL Chemicals & Pharmaceuticals Ltd for NSE is ₹ 24,38.33 Cr. and for BSE is ₹ 24,48.02 Cr. as of now.

What is the 52 Week High and Low of IOL Chemicals & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of IOL Chemicals & Pharmaceuticals Ltd for NSE is ₹ 535.90 and ₹ 330.85 and for BSE is ₹ 535.60 and ₹ 333.00.

How to Buy IOL Chemicals & Pharmaceuticals Ltd share?

Answer Field

You can trade in IOL Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for IOL Chemicals & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 8.14%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader